This position statement is based on a careful assessment of the current literature regarding the benefits and potential risks of the use of simethicone in endoscopy.
Each medical facility should make its own determination regarding the use of simethicone during endoscopic procedures and the route of administration.
Medical facilities that coordinate endoscopy should have access to any information, research or other material which may have been published or become available subsequently so they can reassess their position accordingly.
It is not implied that the statement is applicable in all cases or in any particular case but is a general policy document that may provide guidance for users. Users should use their own judgement and consider the particular circumstances of each case. The user should have regard to any information, research or other material which may have been published or become available subsequently.
This statement is current at the time at which the endorsement is expressed. The statement may be reviewed and updated from time to time. GESA does not take responsibility for reviewing its endorsements and it is the responsibility of the user to ensure they have obtained the current version or are aware of more recent or more appropriate statements.